Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume:1371.29
2.73
-0.11  (-3.87%)
Announcement & Circular
11-17
2016
ANNOUNCEMENT
11-16
2016
CLARIFICATION ANNOUNCEMENT
11-01
2016
Approval for Clinical Trial for New Drug Triptorelin Acetate Extended-release Microspheres for Injection in China
10-04
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2016
09-29
2016
Interim Report 2016
09-06
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2016
08-29
2016
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2016
08-17
2016
NOTICE OF BOARD MEETING
08-09
2016
APPROVAL FOR CLINICAL TRIAL FOR NEW DRUG GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01005) IN CHINA
08-03
2016
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2016
36
37
38
39
40